Chemoinformaics analysis of 5,7-dimethoxy-4-hydroxyflavanone
| Molecular Weight | 300.31 | nRot | 3 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 18 |
| Exact Molecular Weight | 300.1 | nRing | 3 |
| Solubility: LogS | -4.179 | nHRing | 1 |
| Solubility: LogP | 2.527 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 43.0687 |
| nHD | 1 | BPOL | 22.1273 |
| QED | 0.943 |
| Synth | 2.685 |
| Natural Product Likeliness | 1.334 |
| NR-PPAR-gamma | 0.793 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.051 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.635 |
| MDCK | 0.0000277 |
| BBB | 0.108 |
| PPB | 0.922706 |
| VDSS | 0.667 |
| FU | 0.0607448 |
| CYP1A2-inh | 0.783 |
| CYP1A2-sub | 0.908 |
| CYP2c19-inh | 0.951 |
| CYP2c19-sub | 0.711 |
| CYP2c9-inh | 0.881 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.657 |
| CYP2d6-sub | 0.904 |
| CYP3a4-inh | 0.809 |
| CYP3a4-sub | 0.402 |
| CL | 11.991 |
| T12 | 0.351 |
| hERG | 0.056 |
| Ames | 0.37 |
| ROA | 0.43 |
| SkinSen | 0.382 |
| Carcinogencity | 0.605 |
| EI | 0.805 |
| Respiratory | 0.873 |
| NR-Aromatase | 0.095 |
| Antiviral | Yes |
| Prediction | 0.838624 |